Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Giants Rumors

Carlos Correa Taking Physical With Mets Today

By and | at

Carlos Correa is undergoing his physical with the Mets today, agent Scott Boras announced to reporters (including Lindsey Adler of the Wall Street Journal). According to Boras, the Mets are expected to take 24-48 hours to review the results (relayed by Anthony DiComo of MLB.com).

Under normal circumstances, a free agent who has agreed to terms with a team undergoing a physical would hardly be worth noting. In most cases, agreements are reported on before a deal is made official, with the physical a rubber stamp on the way to the official announcement. Of course, the Correa situation has been anything but normal. He agreed to a 13-year, $350MM deal — pending a physical — with the Giants on December 13. That was scuttled on Monday evening when the Giants found something in their examination of Correa that gave them pause. They reportedly wanted more time to look into the medicals but Boras quickly pivoted and secured a new deal with the Mets for 12 years and $315MM. It has occasionally happened before that deals have been scuttled by medicals but never with a player or contract of this magnitude.

The Giants are restricted by HIPAA laws from providing clear answers about the precise nature of the injury. President of baseball operations Farhan Zaidi released a very generic statement on the matter yesterday: “While we are prohibited from disclosing confidential medical information, as Scott Boras stated publicly, there was a difference of opinion over the results of Carlos’ physical examination. We wish Carlos the best.”

Various reports over the past 24 hours have indicated the Giants raised concerns regarded Correa’s right leg. As a prospect in the Astros organization, a then 19-year-old Correa fractured his right fibula while playing in High-A in June 2014. The injury required surgery and cost him the remainder of that season. Last night, Andrew Baggarly of The Athletic wrote about the dilemma and called San Francisco’s concern “pretty obvious” while linking to a 2014 Houston Chronicle story about the fibula fracture.

Jeff Passan of ESPN also indicates the right leg was the issue as part of a wider-ranging piece on the bizarre situation. According to Passan, San Francisco asked Correa’s camp for time to evaluate the issue after identifying their concerns in the physical on Monday night. The team postponed the press conference they’d scheduled Tuesday morning, one clearly designed to formally introduce Correa as a Giant after he signed his contract. That afternoon, the sides reengaged over the phone and the Giants informed Boras they weren’t prepared to keep their 13-year, $350MM offer on the table, Passan writes. San Francisco may have been willing to renegotiate a lower deal, according to Passan, but the decision not to abide by the originally agreed upon terms freed Correa’s camp to explore other opportunities.

In the hours after the Giants deal fell apart, Boras and his staff reached out to both the Mets and Twins. Last night, Andy McCullough, Ken Rosenthal and Will Sammon of The Athletic reported that Correa’s camp had been in touch with Minnesota before agreeing to terms with the Mets. The Twins, Correa’s incumbent team, had put forth a ten-year, $285MM offer earlier in the offseason. According to both The Athletic and ESPN, Minnesota expressed reluctance to move past that proposal on Tuesday evening — at least not without more time to evaluate the concerns raised by the Giants in their exam.

Not long after, Correa and the Mets hammered out the agreement. Both The Athletic and ESPN characterize negotiations as fairly direct between Boras, New York owner Steve Cohen and Mets general manager Billy Eppler. By the middle of the night, Jon Heyman of the New York Post reported the sides were in agreement on their 12-year pact. According to McCullough, Rosenthal and Sammon, Mets manager Buck Showalter and numerous other team officials weren’t aware of the extent of negotiations, learning when they woke up Wednesday morning about the agreement.

That’s all subject to the Mets physical evaluation, of course. However, there doesn’t seem to be much concern within the New York organization about Correa potentially failing a second physical. Cohen discussed the agreement on the record with Heyman; as Andy Martino of SNY wrote yesterday, that’d open the Mets up for a potential grievance if they back out of the deal over concerns about the medicals.

Correa’s camp, predictably, has denied there’s reason for concern. “There is nothing with him that is currently any sort of medical issue,” Boras said this morning, per DiComo. The agent added the Giants were trying to use a “crystal ball” to predict Correa’s long-term health (via Laura Albanese of Newsday).

The right leg that apparently gave the Giants pause has never sent Correa to the injured list as a major leaguer. He missed the second half of the 2014 minor league season recovering from surgery but was back on the field at the start of the following campaign. Correa has had a few injured list stints in the majors, missing time between 2017-19 with a torn ligament in his left thumb, back soreness (twice) and a rib fracture. He also lost a bit of time this past season after bruising his right middle finger. Since making his MLB debut, Correa hasn’t had any IL stints related to his lower half. However, Passan writes that San Francisco’s medical professionals raised concerns about the long-term stability of his right leg, fearing he could quickly lose the lateral mobility that plays such a key role in his defensive projection.

It’s worth pointing out that there is some precedent for the Mets similarly striking down a deal with a player, just as the Giants have done with Correa this week. The Mets selected Kumar Rocker, also represented by Boras, 10th overall in the 2021 draft and agreed to a $6MM signing bonus until they grew concerned by something in his physical and the deal fell apart. Backing out of a $6MM bonus for a draftee and a $315MM agreement with a superstar are two different things, however, and Cohen’s on-record discussions of the Correa agreement reiterate the owner’s confidence in the exam going without issue.

It has been a rollercoaster for Correa over the past two years, having reached free agency for the first time after the 2021 season. He went into the open market seeking a deal of ten-plus years in length and over $300MM but didn’t find one before the sport went into a lockout in December. During that lockout, he fired his representatives and hired Boras. After the lockout, he still didn’t find the megadeal he was looking for, but settled on a three-year contract with Minnesota that paid him a huge $35.1MM annual salary and allowed him to opt out after each season.

After another solid performance in 2022, he returned to the open market and seemed to finally land the deal he wanted with San Francisco. That’s gone but he secured another within hours from the Mets. There’s one step to go, perhaps the most anticipated physical examination in baseball history.

White Sox Acquire Gregory Santos

By | at

The White Sox are acquiring reliever Gregory Santos from the Giants, reports Robert Murray of FanSided. Santos was recently designated for assignment by the Giants. The White Sox have since announced the deal, with minor league right-hander Kade McClure going the other way.

Santos, 23, began his career in the Red Sox organization but came to the Giants in the 2017 deadline deal that sent Eduardo Núñez to Boston. The Giants were impressed enough with his development to give him a 40-man roster spot ahead of the 2020 Rule 5 draft. In 2021, Santos made a brief MLB debut but was handed an 80-game suspension in June after testing positive for Stanozolol, a banned performance-enhancing drug.

In 2022, Santos served as optional depth, throwing just 3 2/3 innings in the big leagues. In 33 Triple-A innings, he posted a 4.91 ERA with strong strikeout rate and ground ball rates of 23% and 51.7%, respectively. However, control was an issue with Santos walking 13.5% of batters faced, something that has been a persistent problem in recent years. He has a 16.7% walk rate in his brief MLB tenure as well.

Despite those control issues, the White Sox are likely interested in the power of his arm, as his fastball averaged at 98.8 mph in his brief showing this year. He’s also still quite young and has one option year remaining, allowing him to serve as depth in the minor leagues.

McClure, 27 in February, was a sixth round selection of the White Sox in 2017. He worked his way up the minors as a starting pitcher, posting decent enough results for Baseball America to deem him the #20 White Sox prospect going into 2021. Unfortunately, he reached Triple-A that year and struggled by posting a 6.81 ERA. In 2022, the Sox shifted him to the bullpen, as he made just five starts and 39 relief appearances. His 4.97 ERA in Triple-A this year still isn’t great, but he did have solid peripherals with a 24.8% strikeout rate, 7.2% walk rate and 39% ground ball rate.

Scott Boras Comments On Carlos Correa Situation

By | at

The past week has seen an incredible free agent plot twist that’s unprecedented in baseball history. Reports emerged last week indicating that the Giants had agreed to terms with shortstop Carlos Correa on a 13-year, $350MM deal. That deal, like all free agent agreements, was pending a physical. However, it was reported yesterday that an issue flagged during Correa’s physical caused the Giants to delay a press conference that was set to introduce Correa. That was followed by a stunning middle-of-the-night report that Correa had a new agreement with the Mets for 12 years and $315MM.

The entire baseball world is still trying to piece together how such a strange sequence of events came to pass. Correa’s agent, Scott Boras, has provided his perspective today, giving comment to Susan Slusser of the San Francisco Chronicle and Ken Rosenthal of The Athletic.

“We reached an agreement. We had a letter of agreement. We gave them a time frame to execute it,” Boras said. “They advised us they still had questions. They still wanted to talk to other people, other doctors, go through it. I said, ‘Look, I’ve given you a reasonable time. We need to move forward on this. Give me a time frame. If you’re not going to execute, I need to go talk with other teams.”

It still isn’t publicly known what issue the Giants found during Correa’s physical, but Boras frames it as an old injury that precedes Correa’s time in the majors. “You’re talking about a player who has played eight major-league seasons,” Boras said. “There are things in his medical record that happened decades ago. These are all speculative dynamics. Every team has a right to go through things and evaluate things. The key thing is, we gave them (the Giants) medical reports at the time. They still wanted to sign the player and negotiate with the player.”

Rosenthal lays out that Correa suffered a season-ending leg injury in the minor leagues in 2014 but he has not been on the injured list for a lower leg injury since his promotion to the majors. He’s also had back issues in the past but his last IL stint for a back injury was in 2019.

Giants president of baseball operations Farhan Zaidi also provided a comment, though without getting into specifics. “While we are prohibited from disclosing confidential medical information, as Scott Boras stated publicly, there was a difference of opinion over the results of Carlos’ physical examination,” Zaidi said to reporters, including Alex Pavlovic of NBC Sports Bay Area. “We wish Carlos the best.”

It’s worth reiterating that, with the Giants not providing any details, we only really have one side of the story. As Correa’s agent, Boras is surely motivated to wipe away the concern of the Giants as unreasonable or a non-issue. Correa’s new deal with the Mets is also pending a physical and won’t be official until that is complete. However, if the Mets end up having the same concerns as the Giants, it might be difficult for them to back out in a similar fashion. Andy Martino of SNY reports that the Mets could face a grievance if they back out of the deal since owner Steve Cohen has already discussed the deal on the record.

Also noted by Rosenthal, it’s not entirely unprecedented for medical personnel to come to different conclusions about the health of a player. This Boras-Mets situation was the other way around with Kumar Rocker, whom the Mets selected 10th overall in the 2021 draft. The Mets had agreed to give Rocker, who is represented by Boras, a $6MM bonus before medical concerns scuttled the deal. Rocker re-entered the draft a year later and was selected third overall by the Rangers.

It has also occasionally happened in the past that free agents agree to terms with teams but then issues pop up with the physical before the deal is official. In one recent example, reliever Grant Balfour agreed to terms with the Orioles on a two-year, $15MM deal prior to the 2014 season. The O’s backed out after conducting Balfour’s physical and he instead signed with the Rays for two years and $12MM. However, a similar situation for a free agent of Correa’s magnitude hasn’t been seen before.

Yankees Sign Carlos Rodon To Six-Year Deal

By | at

December 21: The Yankees have officially announced the signing.

December 15: The best remaining free agent starter is headed to the Bronx. The Yankees are reportedly in agreement on a six-year, $162MM contract with Carlos Rodón. The Boras Corporation client will receive a $5MM signing bonus and a $22MM salary next season followed by successive $27MM salaries from 2024-28. The deal contains a full no-trade clause and runs through Rodón’s age-35 season.

New York pairs the addition with their record-setting deal for defending AL MVP Aaron Judge as part of a huge offseason. The guarantee ties that of Brandon Nimmo for the sixth-largest deal of the offseason. Rodón will finish with the second-largest guarantee among free agent pitchers, narrowly behind the five-year, $185MM pact Jacob deGrom inked with the Rangers.

It’s the culmination of an incredible two-season run. The left-hander entered the professional ranks eight years ago, selected by the White Sox with the third overall pick in the 2014 draft. Owner of a mid-90s fastball and a wipeout slider, he was regarded as a potential top-of-the-rotation starter who’d quickly reach the big leagues. Rodón indeed found himself on Chicago’s south side by the middle of the 2015 campaign, and he posted a 3.90 ERA in 304 1/3 innings through the end of the following season.

Unfortunately, the Miami native’s career was then sidetracked by injuries. Rodón lost a chunk of the 2017 campaign to biceps bursitis, then underwent arthroscopic shoulder surgery that September. He didn’t debut until June the following year, making 20 starts. Early the next season, Rodón was diagnosed with an elbow issue. He went back under the knife in May ’19, this time undergoing a Tommy John procedure. He missed the remainder of that year, returning at the tail end of the 2020 campaign for four appearances.

The mounting injury troubles led the White Sox to decline to tender him a contract heading into 2021. Chicago circled back towards the end of the offseason, bringing him back on a $3MM free agent deal. That move was met with a fair amount of criticism, but it turned into one of the best decisions of GM Rick Hahn’s tenure.

Rodón was brilliant in 2021, earning his first All-Star nod with a 2.31 ERA over 89 2/3 first-half innings. He looked on his way to a Cy Young award when he dealt with some shoulder fatigue in August. Rodón only missed a couple weeks and continued to pitch well upon his return, although his velocity dropped towards season’s end. The southpaw concluded the year with a 2.37 ERA and a massive 34.6% strikeout percentage across 132 2/3 innings. He placed fifth in Cy Young balloting.

The end-of-year shoulder issue and velocity dip seemed to scare the Chicago front office, however. They made the eyebrow-raising decision not to issue Rodón a qualifying offer, allowing him to hit the open market without draft compensation attached. He remained a free agent until after the lockout, when the Giants added him on a two-year, $44MM guarantee. The deal contained an opt-out clause after year one, conditional on Rodón reaching 110 innings pitched in 2022. It was an opportunity for the star hurler to bet on himself, knowing a nine-figure deal could be in the cards if he maintained his 2021 form over a full, healthy season.

Rodón did exactly that, doubling down with perhaps the best season of his career. He stayed healthy all year, making 31 starts and tallying a personal-high 178 innings. Rodón worked to a sterling 2.88 ERA. He earned a second straight All-Star nod and was among the game’s best at missing bats. Rodón fanned 33.4% of opponents against a solid 7.3% walk rate. Among pitchers with 100+ innings, only Braves rookier Spencer Strider bested that strikeout percentage. Strider, Shohei Ohtani, Max Scherzer and Gerrit Cole were the only pitchers with a larger gap between their strikeout and walk rates.

Almost as importantly, Rodón’s arsenal showed no ill effects after his 2021 dip. His fastball averaged a strong 95.5 MPH, making him one of the game’s harder-throwing lefty pitchers. He generated high-end spin and whiff rates on both his fastball and slider, and opposing hitters swung through a massive 14.1% of his total pitches. Rodón stifled batters from both sides of the plate; he held lefties to a .179/.257/.260 line, while hitters with the platoon advantage put together just a .207/.264/.319 mark.

A second season of elite performance, this one without any health scares, cemented the 30-year-old as one of the sport’s top pitchers. His career took a more winding road than expected when he was drafted, but Rodón has developed into a top-of-the-rotation starter. He made the easy decision to opt out of his deal with San Francisco after topping the necessary innings threshold, and he quickly turned down a qualifying offer.

It now looks like a potentially elite Yankee rotation. New York watched Jameson Taillon depart but upgrades with the Rodón addition. He and Cole are co-aces, backed up by breakout hurler Nestor Cortes, Luis Severino and Frankie Montas. The latter two have had some injury concerns in recent seasons, but they’re overqualified as fourth and fifth starters if healthy. Domingo Germán, Clarke Schmidt and prospect Randy Vasquez are on hand as depth options who could step in if any of the top five get injured.

Rodón was one of three aces available in free agency, jointing deGrom and Justin Verlander. As the youngest of that trio, he always looked likely to secure the longest deal. The six-year term will be the longest for any pitcher this winter, although deGrom’s five-year contract and the stronger than expected market for mid-tier starters led to rumors Rodón’s camp was seeking a seven-year pact that’d push past $200MM. He falls well shy of that lofty hope, but the six-year, $162MM commitment is still quite strong for a pitcher.

It’s the first six-year commitment for a free agent pitcher since Cole and Stephen Strasburg pushed to nine and seven years, respectively, over the 2019-20 offseason. Patrick Corbin ($140MM) and Yu Darvish ($120MM) are the only other open market hurlers to reach six years since the start of the 2016 campaign. At the start of this offseason, MLBTR forecasted Rodón for a five-year, $140MM pact.

The cost for New York goes beyond the salary they’ll owe, as the deal pushes them even further into luxury tax territory. The Yankees were already set to pay the competitive balance tax, and adding Rodón pushes them towards the top tier of penalization. The contract comes with a $27MM average annual value, bringing New York’s CBT figure within a rounding error of the $293MM mark, according to Roster Resource. That’s the cutoff for the fourth CBT tier and places them around $60MM north of the $233MM base threshold.

New York also paid the luxury tax in 2022, so they’ll be subject to heightened penalties as a repeat payor. The Yankees will pay a 30% tax on their first $20MM in overages ($6MM), 42% on their next $20MM ($8.4MM), 75% on the next $20MM ($15MM) and 90% on every dollar spent above $293MM. Signing Rodón pushes them firmly to the top of the third threshold, essentially tacking on around $18MM in taxes. The $27MM salary will bring their raw payroll total around $277MM, which’ll easily be a franchise record.

Going past the third threshold will also push the Yankees first draft choice in 2024 down ten spots. Meanwhile, signing a player who’d turned down a qualifying offer will have a significant impact on their 2023 draft. New York is subject to the highest penalties as a team that paid the CBT this year. They’ll lose their second and fifth-highest selection in next summer’s amateur draft, while their international bonus allotment will drop by $1MM.

The Giants will receive compensation for Rodón’s departure. As a team that neither received revenue sharing payments nor paid the CBT this year, they’ll pick up a bonus selection between Competitive Balance Round B and the start of third round (typically around 75th overall) in next year’s draft. San Francisco had seemingly prepared for Rodón’s departure from the roster by making a pair of their preferred shorter-term rotation additions, bringing aboard Sean Manaea and Ross Stripling on two-year guarantees.

With Ródon off the board, Dansby Swanson is the last remaining free agent who’s likely to find a nine-figure deal. The free agent rotation market has mostly been covered at the top end, with Nathan Eovaldi, Michael Wacha, Johnny Cueto, Corey Kluber and Drew Rucinski standing as some of the top options still available. Needless to say, none of that group has the kind of upside Rodón does. It’s a bold bet from the Yankees, one they hope adds an impact arm to their playoff rotation as they look to advance past the AL Championship Series for the first time since 2009.

Jon Heyman of the New York Post first reported Rodón and the Yankees had agreed to a six-year, $162MM deal that contained a full no-trade clause. Bob Nightengale of USA Today was first to report the specific financial breakdown.

Image courtesy of USA Today Sports.

Mets To Sign Carlos Correa

By | at

In a shocking development, Carlos Correa has agreed to join the Mets for a 12-year, $315MM contract, Jon Heyman of the New York Post reports.  Correa had previously agreed to a 13-year, $350MM deal with the Giants, yet reports surfaced yesterday that an unknown issue with Correa’s medicals had led to a postponement of the Giants’ introductory press conference for the shortstop.  The 28-year-old Correa is represented by the Boras Corporation, and his deal with the Mets will become official once he passes a physical.

As Susan Slusser of the San Francisco Chronicle tweets, the “Giants flagged something in [Correa’s] physical and doctors disagreed.”  Slusser also reported yesterday that Correa’s back wasn’t the issue, though back soreness has sent the former All-Star to the injured list on multiple occasions during his career.

Whatever the Giants took issue with in Correa’s physical, obviously the problem wasn’t enough to deter the Mets from adding yet another high-priced star to their already loaded roster (and payroll).  Mets owner Steve Cohen said last week that the team made a late bid of around $300MM to land Correa, but that offer was turned down by agent Scott Boras since talks with the Giants had already reached an advanced stage.

As it turned out, that late attempt from Cohen was seemingly all Boras needed to secure another mega-deal for his client quickly after the agreement with San Francisco fell apart.  As Cohen told Heyman, “we kind of picked up where we were before and it just worked out” over the course of four or five hours’ worth of extra negotiations.

Correa’s new contract with New York is one year shorter and worth slightly less in average annual value ($26.25MM with the Mets compared to $26.92MM with the Giants).  It is also “only” now the 10th-largest contract in baseball history in terms of total value, while the $350MM deal with San Francisco was the fourth-largest in history.

Still, the deal handily surpasses MLBTR’s projection of a nine-year, $288MM pact for Correa.  Like the structure of the original Giants contract as well as other deals signed by Xander Bogaerts and Trea Turner this winter alone, the longer length allows the team to spread out the luxury-tax hit over more years, while the player still gets his money as well as extra security.  The Mets themselves used a version of this strategy in re-signing Brandon Nimmo to an eight-year, $162MM deal, as Nimmo’s tax number is $20.25MM.  Correa now joins Nimmo and Francisco Lindor as Mets players signed beyond the 2029 season, though the Mets’ expenditures this winter have varied widely in length.

The overall numbers of the Mets’ spending spree continue to stagger.  Assuming Correa’s contract pays him $26.25MM in each year of the deal, the Amazins’ payroll will now soar past the $377MM mark for 2023.  Having already far surpassed the fourth and highest tier ($293MM) of Competitive Balance Tax penalties, New York is paying a 90% tax on every dollar spent beyond the $293MM threshold.  That works out to roughly $23.62MM added to the Mets’ tax bill, thus putting their luxury tax number over $386MM.

Correa, Nimmo, Justin Verlander, Edwin Diaz, Kodai Senga, Jose Quintana, David Robertson, Adam Ottavino, and Omar Narvaez represent the star-studded list of free agents signed and re-signed by New York this offseason alone, to say nothing of their previous big splashes since Cohen bought the team just over two years ago.  Needless to say, Cohen has established new standards for spending, as the owner has made no qualms about his desire to immediately make the Mets as competitive as possible.  The result was a 101-win season in 2022, but the Amazins didn’t make it past the first round of the expanded playoffs, losing to the Padres in three games in the Wild Card Series.

The Correa signing “really makes a big difference,” Cohen said.  “I felt like our pitching was in good shape.  We needed one more hitter.  This puts us over the top.”

Indeed, most of the Mets’ focus had been on revamping a rotation and bullpen that was full of free agents.  While Diaz and Ottavino were re-signed, plenty of holes had to be filled after Jacob deGrom, Chris Bassitt, Taijuan Walker, Seth Lugo, Joely Rodriguez, Trevor Williams, Trevor May, and Mychal Givens all signed elsewhere.  Nimmo was the biggest pending free agent on the position player side, and Narvaez should help bolster the catching corps, but Cohen and GM Billy Eppler weren’t going to curb their aggressiveness.

To this end, one of baseball’s best shortstops in Correa now won’t even be a shortstop, as Correa will now move to third base in deference to Lindor.  Correa won a Platinum Glove, Gold Glove, and Fielding Bible Award for his work at shortstop just in 2021, and his professional experience at third base consists of one game with the Astros’ Double-A affiliate in 2015.  That said, Lindor is an excellent fielder in his own right, and the Outs Above Average and UZR/150 public metrics prefer his glovework at shortstop to Correa’s over the course of their careers.  There isn’t much doubt that Correa should be able to translate well to the hot corner, thus improving the Mets’ defense as well as the impact he’ll bring to the lineup.

With Correa now the new third baseman, Eduardo Escobar is suddenly out of a starting job.  It wasn’t even 13 months ago that Escobar was one of New York’s big signings of the 2021-22 offseason, as he inked a two-year, $20MM deal.  Escobar was decent if unspectacular, hitting .240/.295/.430 with 20 homers for a 106 wRC+ over 542 plate appearances in his first year in Queens.

“Decent if unspectacular” wasn’t enough for a team so intent on winning, however, and thus Escobar could now join Luis Guillorme as infield depth.  It stands to reason that the Mets could explore trading Escobar (and the $10MM remaining on his deal) to a team in need of a dependable veteran infielder, or New York could simply keep Escobar as a backup option in the event of an injury to Correa or starting second baseman Jeff McNeil.

Looking further down the depth chart, top prospect Brett Baty is also a third baseman, as is Mark Vientos (ranked by MLB Pipeline as the seventh-best minor league in New York’s farm system).  Baty has gotten some time as an outfielder and now might be viewed as a possible replacement for Canha in left field, while Vientos might be destined for a move off third base anyway, with first base potentially being his ultimate spot on the field.  With Correa now locked into the hot corner, however, there seems an increased possibility that the Mets could shop either of these prospects for other upgrades.

Today’s news marks the latest twist in a controversy-filled career for Correa, largely tied to his participation on the 2017 Astros team that won a World Series championship later clouded by the sign-stealing scandal.  Correa’s time in Houston ended when he signed a three-year, $105.3MM deal with the Twins last winter, though that shorter-than-expected contract was designed to allow a quick return to the free agency.  Correa had opt-out clauses after both the 2022 and 2023 campaigns, and he exercised that first opt-out to re-enter the market in an offseason that wasn’t interrupted by the lockout.

Correa hit .291/.366/.467 with 22 homers over 590 plate appearances in his lone season in Minnesota, with a 140 wRC+ that stands as the third-highest of his eight MLB seasons.  Coming off a strong platform year and still being younger than most free agents once they reach the open market, Correa had every expectation of finally landing the pricey long-term contract he initially wanted last year.

The result was two pricey, long-term contracts, with the Mets swooping in to take Correa away from the Giants.  It’s probably wise to not totally assume Correa’s pact with the Mets is a done deal until the physical is passed and an official announcement is made, given the stunning nature of the last 24 hours.  Yesterday’s reports of a delay certainly raised red flags about the status of Correa’s agreement with San Francisco, but with an absence of any concrete news, there wasn’t yet any reason to believe that Correa wouldn’t still eventually end up in the Bay Area.

Instead, the Giants’ winter plans have now been dealt an almost unfathomable setback.  The Giants slumped to an 81-81 record after their 107-win season in 2021, leaving president of baseball operations Farhan Zaidi in search of a major acquisition.  San Francisco has lots of payroll space and lots of needs around the roster to accommodate at least one new superstar, and there seemed little doubt that the Giants were lining up to make the first true blockbuster signing of Zaidi’s four-year tenure.

Aaron Judge was clearly the top priority heading into the offseason, and the Giants reportedly offered Judge around $360MM before the AL MVP took that same salary over a nine-year deal to re-sign with the Yankees.  With Judge off the board, San Francisco then turned to the shortstop market, with Correa emerging as their top target (ahead of Turner, Bogaerts, or Dansby Swanson).  The $350MM deal represented the biggest contract in franchise history, and a resounding counter to any argument that the Giants’ front office was unwilling or unable to land top-tier free agents.

It isn’t exactly true that the Giants are back to square one, since they’ve also signed Mitch Haniger, Ross Stripling, and Sean Manaea in free agency, and Joc Pederson was retained via the qualifying offer.  But, Carlos Rodon left the team to also sign with the Yankees, removing another star from the 2022 roster.  The league-wide rush on free agent signings has left the market bare of most of the top names, and so Zaidi and company will now have to explore the trade market (and possibly make some tough decisions on trading top prospects) in order to acquire another big-ticket star….if one is even necessarily available.

Speculatively, the Giants could try to wield their payroll space in a different manner, perhaps by offering a deal for both a star player and an undesirable contract on a team looking to cut spending.  With over three months until Opening Day, there’s plenty of time left for the Giants to still make moves, and yet it’s hard to imagine they can make an addition anywhere near Correa’s level.

Photo courtesy of USA Today Sports Images

Originally posted at 2:05am.

Giants Reportedly Postpone Carlos Correa’s Introduction Due To Medical Concern

By | at

The Giants and Carlos Correa agreed to terms last week on a 13-year, $350MM framework for a deal. That structure was pending a physical and Correa had yet to officially sign the contract. The club was going to introduce him today but the scheduled news conference was postponed due to a medical concern, reports Ronald Blum of the Associated Press. Earlier today, Susan Slusser of the San Francisco Chronicle reported that the postponement was related to the fact that the club was “awaiting test results.” At this point, it isn’t known what exactly is causing the holdup, with Blum’s report simply stating that “a medical issue was flagged.”

Beyond that information, anything else is speculation at this point. It isn’t publicly known what the issue is or how serious it is. It’s also not known if the Giants simply want to conduct further tests or have firm evidence of something that will lead to the deal being called off or restructured. However, the fact that they are at least delaying the official stamp is a situation that will be worth monitoring.

Over the past eight seasons, Correa has been one of the best shortstops in baseball but one knock against him has been durability. He has gone to the injured list with various issues in his career, including a torn ligament in his thumb, lower back soreness and a fractured rib. However, he largely moved past his “injury-prone” label in recent years. He played 58 games in the shortened 60-game season in 2020, followed by 148 contests in 2021. This most recent season, he went on the IL for a finger contusion and went to the COVID-IL once but still got into 136 games on the year, staying healthy for the entirety of the second half of the season. Again, it’s worth repeating that we don’t know what the current issue is or the severity of it, but Slusser reports that is not a back problem.

Giants Designate Gregory Santos For Assignment

By | at

The Giants announced that they have designated right-hander Gregory Santos for assignment. The club will need to open one more roster spot, to allow for recent signees Sean Manaea and Carlos Correa to fit onto the 40-man.

Santos, 23, began his career in the Red Sox organization but came to the Giants in the 2017 deadline deal that sent Eduardo Núñez to Boston. The Giants were impressed enough with his development to give him a 40-man roster spot ahead of the 2020 Rule 5 draft. In 2021, Santos made a brief MLB debut but was handed an 80-game suspension in June after testing positive for Stanozolol, a banned performance-enhancing drug.

In 2022, Santos served as optional depth, throwing just 3 2/3 innings in the big leagues. In 33 Triple-A innings, he posted a 4.91 ERA with strong strikeout rate and ground ball rates of 23% and 51.7%, respectively. However, control was an issue with Santos walking 13.5% of batters faced, something that has been a persistent problem in recent years. He has a 16.7% walk rate in his brief MLB tenure as well.

The Giants will have one week to trade Santos or pass him through waivers. Despite those control issues, there are reasons Santos might find some interest from other clubs. He’s still quite young and has one option year remaining, allowing him to serve as depth in the minor leagues. He also has excellent velocity, with his fastball averaged at 98.8 mph in his brief showing this year. For any club that feels they can better harness that power, Santos could be a worthwhile pickup.

Steve Cohen Discusses Mets’ Pursuit Of Carlos Correa: “We Got There Late”

By | at

Just before Carlos Correa signed his 13-year, $350MM deal with the Giants, the Mets made an attempt to try land the star shortstop.  Mets owner Steve Cohen shed more light on that pursuit in an interview with Jon Heyman of the New York Post, as Cohen said that he contacted Correa’s agent Scott Boras an offer of roughly $300MM.  By that point, however, the Giants and Correa’s camp were already deep enough into negotiations that Boras and company didn’t want to turn back.

As Cohen simply put it, “we got there late” on Correa’s market.  “We thought maybe he might fall to us….He’s a great leader and a good guy.  He could play third base.  And he’s a great defender.”

Position changes have been floated for all of Correa, Xander Bogaerts, Trea Turner, and Dansby Swanson in various permutations by several teams this winter, as even at the very top of the shortstop market, clubs creatively explored ways to fit these players into a lineup even if another good shortstop was already on the roster.  In New York, of course, Francisco Lindor is already locked into the shortstop role through the 2031 season, and thus Correa would’ve had to move to the hot corner.

Lindor’s presence made the Mets something of a bystander on the shortstop market, but when Correa lingered on the market, Cohen checked in with Boras to see if something could be done.  Eduardo Escobar (signed to a two-year, $20MM deal just last offseason) is the Mets’ current third baseman, but if Correa had been signed, Escobar would’ve presumably become an overqualified utility infielder, or perhaps a trade chip.

It’s also fair to say that Cohen’s attention might’ve been busy elsewhere, preventing him from making an earlier bid on Correa.  New York has already re-signed Edwin Diaz and Brandon Nimmo, and brought Justin Verlander, Kodai Senga, Jose Quintana, David Robertson, and Omar Narvaez into the fold during an extraordinary free agent splurge.  The result is a payroll that sits at roughly $343.56MM, and a luxury tax number of $356.3MM — both records in MLB history.

“No one likes to spend money.  But this is the price” of doing business, Cohen said, as the Mets want to win but aren’t interested in trading from their farm system.  If this means operating at a loss in order to chase a World Series, that is fine in Cohen’s view.  Also, the owner noted that the club also had a lot of holes to fill (mostly on the pitching staff) given its own extensive free agent class.  While Nimmo and Diaz were retained, Jacob deGrom, Taijuan Walker, Chris Bassitt, Trevor May, Trevor Williams, and Joely Rodriguez have all signed elsewhere.

“My team is good.  But it isn’t that much better than last year.  If you want a team that’s good, this is what it costs.  What are you going to do?” Cohen asked rhetorically.

As much as there doesn’t appear to be a limit on New York’s spending, Cohen did say that Correa’s market conditions played a role in the Mets’ interest, as he was going to pursue a signing “that made sense…and not get crazy.”  The fact that a $300MM offer on top of the Mets’ other spending doesn’t qualify as “crazy” is yet another eye-popping example of how Cohen is redefining baseball’s payroll limits, and yet “I’ve been dealing with big numbers for so long these numbers don’t scare me at all.  It’s not like I’m not respectful about what these other teams have to deal with.”

Giants, Nick Duron Agree To Minor League Deal

By | at

The Giants have signed reliever Nick Duron to a minor league contract, according to his transactions log at MLB.com. The 26-year-old joins the fourth organization of his professional career.

Duron entered the pro ranks in 2015, selected by the Red Sox in the 31st round out of Clark College in Washington. He spent a few seasons in the Boston system but didn’t advance past Low-A before being released in 2018. Signed to a minor league deal by the Mariners, he pitched his way to Triple-A in 2021 before qualifying for minor league free agency. Last winter, Duron hooked on with the Phillies on a minor league pact.

The 6’4″ hurler would again spend most of the season in Triple-A, but he earned a cup of coffee at the MLB level. Duron was called to the majors in July as a replacement for unvaccinated players in a series in Toronto. He came out of the bullpen once, working around two hits to get out of a scoreless inning. After the contest, Philadelphia returned him to Triple-A Lehigh Valley, where he spent the remainder of the season before again hitting minor league free agency.

While Duron only has that one inning of MLB experience, he’s an interesting depth flier for the Giants. He averaged 97.2 MPH on his fastball during his MLB appearance. That strong velocity translated into plenty of whiffs in the minors, as he struck out a strong 29.6% of opponents over 48 2/3 innings for the IronPigs. Duron walked an alarming 13.6% of batters faced, but the strikeouts and a lofty 50.4% ground-ball percentage helped him to a 2.77 ERA.

Duron’s control has been inconsistent, but he’s flashed decent stuff and is coming off a career-best showing in Triple-A. He’ll presumably start next year with the Giants highest affiliate in Sacramento but could put himself in the mix for an MLB bullpen job at some point. Duron has all three option years remaining, so if he cracks the 40-man roster at any point, the Giants can freely move him between San Francisco and Sacramento for a long while.

Giants Sign Sean Manaea

By and | at

DECEMBER 16: The Giants have officially the signing of Manaea.

DECEMBER 12: Lefty Sean Manaea and the Giants have agreed to a two-year, $25MM deal with an opt-out after the 2023 season, according to Jon Heyman of the New York Post. Manaea is represented by the Boras Corporation.

The deal marks a return to the Bay Area for the 30-year-old Manaea, who was traded from Kansas City to Oakland as a prospect at the 2015 trade deadline as part of the Ben Zobrist deal. Manaea debuted for the A’s the following year and was a steady presence in their rotation throughout his six seasons in Oakland, though he did miss most of the 2019 season after undergoing shoulder surgery.

Still, with both his career ERA (3.86) and FIP (3.96) under 4.00, Manaea was a fairly attractive arm to teams searching for rotation help after the lockout ended this spring, and so the A’s shipped him to San Diego along with relief prospect Aaron Holiday to acquire prospects Euribiel Angeles and Adrian Martinez. Things didn’t go so well for Manaea in San Diego, however, as he struggled in 2022, posting an unsightly 4.96 ERA (75 ERA+) in 158 innings that his 4.53 FIP only slightly improves upon.

That rough platform season is likely why Manaea was available to San Francisco, who showed interest in him during last week’s Winter Meetings, at such a low price compared to what we’ve seen from the rest of the mid-rotation market. It’s of course possible that Manaea eschewed a larger guarantee in order to secure a chance to test the market again next offseason, hoping to see his results improve in 2023.

In that regard, the deal is similar to the one the Giants signed Carlos Rodon to last offseason, albeit at a much lower AAV of just $12.5MM compared to Rodon’s $22MM. Manaea may prove to be Rodon’s replacement in a rotation that includes Logan Webb, Alex Cobb, Alex Wood, and Anthony DeSclafani, should Rodon ultimately sign elsewhere this offseason. Rodon is known to be seeking a seven-year deal this offseason, with the Cardinals and Yankees among those interested.

While it seems unlikely Manaea can imitate Rodon’s sterling 2022 production in 2023, there’s still reason to believe that Manaea can bounce back from his difficult 2022 in the coming season. His strikeout and walk rates of 23.2% and 7.5%, respectively, are roughly in line with his career norms and were actually slightly above league average last year according to Baseball Savant. And for the season’s first three months, Manaea’s numbers were right in line with his career marks. Through the end of June, he’d posted a 3.92 ERA and 3.76 FIP with a 25.8% strikeout rate and 9% walk rate. Over the final three months of the season, however, Manaea was rocked for an ERA just over 6.00, with a huge portion of the damage coming in a pair of eight-run drubbings at Dodger Stadium.

Manaea’s biggest problem in 2022 was the long ball, as he allowed a whopping 1.65 home runs per nine innings that doubtlessly contributed to his strand rate of just 67.5% — his lowest in any full season of his career. Moving his home games Oracle Park, one of the most difficult ballparks in the majors for home run hitters, should aid Manaea in his bid to return to form in 2023. If Manaea can post a season more in line with his 2021 performance, where he posted a 3.91 ERA/3.66 FIP in his 179 1/3 innings of work, he’ll justify the investment from San Francisco and be in line for a larger deal, more in line with the four-year, $52MM guarantee MLBTR predicted for him this offseason.

With their starting five for 2023 likely set barring another surprise addition, the Giants seem primed to turn their attention to the lineup, which largely struggled in 2022 with the exception of All-Star Joc Pederson, who returned to the Giants by accepting a qualifying offer early in the offseason. San Francisco already added Mitch Haniger but is rumored to be interested in adding a second outfielder, even after missing on pursuits of Aaron Judge, Brandon Nimmo, and Cody Bellinger.

The Giants are also are expected to address an infield that lost Brandon Belt and Evan Longoria to free agency this offseason, while suffering a considerable step back from shortstop Brandon Crawford after his resurgent 2021 season. The Giants reportedly have Carlos Correa as their top option in the free agent shortstop market, with the Twins and Cubs representing possible competition for Correa’s services. San Francisco also seems likely to look to upgrade their relief corps for next season. Earlier, they were rumored to have interest in pairing Kenley Jansen, who signed with the Red Sox, with Camilo Doval at the back of their bullpen, so a pursuit of another back-end bullpen option like Taylor Rogers seems feasible.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top